^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IGM-2644

    i
    Other names: IGM-2644, CD38 x CD3 based IgM bispecific antibody, IGM2644, IGM 2644
    Associations
    News
    Trials
    Company:
    IGM Biosciences
    Drug class:
    CD3 agonist, CD38 inhibitor
    Related drugs:
    Associations
    News
    Trials